A needle type therapeutic system incorporating laser light and lumin for immunotherapy of cancer growing in deep organs.
Lumin is a potent cell-activating agent and a photosensitizer characterized by absorption peaks at 670 nm and 770 nm. It has already been demonstrated that macrophase activity is enhanced greatly by lumin administration with laser light irradiation and that this method is useful in cancer immunotherapy. In this study, a new needle type therapeutic system was developed for the immunotherapy of cancer growing in deep human organs. A human lung cancer grafted onto nude mice was strongly cicatrized by collagen fibres about four weeks after the first treatment. The collagen fibres seemed to seal-off the tumor and prevent its growth with intense cicatrization. In addition, a high T/B cell ratio of lymphocytes was observed in the peripheral blood of the treated mice, although the thymus is congenitally absent from nude mice. These results demonstrated that the system is a reliable method for cancer treatment in deep organs without side effects and/or major surgical intervention.
Mito
K
K
Kawasaki College of Allied Health Professions, Kurashiki, Japan.
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy*; D000818:Animals; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D053685:Laser Therapy; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*; D016131:Lymphocyte Subsets / Q000187:drug effects; D008262:Macrophage Activation / Q000187:drug effects*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009339:Needles; D009368:Neoplasm Transplantation; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011806:Quinolinium Compounds / Q000494:pharmacology / Q000627:therapeutic use*
D017319:Photosensitizing Agents; D011806:Quinolinium Compounds; C052194:lumin